20880000|t|Does apolipoprotein E genotype modify the clinical expression of ALS?
20880000|a|BACKGROUND: The presence of the apolipoprotein E (ApoE) 4 genotype is associated with an earlier age of onset for Alzheimer's disease (AD) and several other neurodegenerative disorders. The objective of this study was to investigate the effect of ApoE genotypes on the clinical course of amyotrophic lateral sclerosis (ALS). METHODS: Eight hundred and fifty-two consecutive patients with sporadic ALS evaluated at a tertiary care center were investigated for the effect of ApoE genotype on age of onset, rate of motor disease progression, cognitive functioning, and survival in ALS. RESULTS: The frequencies of individual ApoE genotypes did not differ between patients with ALS and ALS-free Caucasian populations. Patients with different ApoE genotypes did not differ in the age of onset for ALS (years) (ApoE2 = 57.8 +- 13.7, ApoE3 = 57.3 +- 13.7, ApoE4 = 57.7 +- 13.2; P = 0.97), the rate of disease progression (Appel ALS score/month) (ApoE2 = 2.91 +- 2.66, ApoE3 = 2.67 +- 2.66, ApoE4 = 2.61 +- 2.47; P = 0.89), cognitive status (% cognitively impaired) (ApoE2 = 31.7, ApoE3 = 26.8, ApoE4 = 34.3, P = 0.28), or survival in years (ApoE2 = 3.79 +- 3.70, ApoE3 = 3.17 +- 2.27, ApoE4 = 3.05 +- 1.75; P = 0.85). CONCLUSIONS: Our results suggest that ApoE genotype does not modify clinical course of sporadic ALS, in stark contrast to the influence of ApoE genotype on the disease course of AD and other neurodegenerative disorders.
20880000	5	21	apolipoprotein E	Gene	348
20880000	65	68	ALS	Disease	MESH:D000690
20880000	102	125	apolipoprotein E (ApoE)	Gene	348
20880000	184	203	Alzheimer's disease	Disease	MESH:D000544
20880000	205	207	AD	Disease	MESH:D000544
20880000	227	254	neurodegenerative disorders	Disease	MESH:D019636
20880000	358	387	amyotrophic lateral sclerosis	Disease	MESH:D000690
20880000	389	392	ALS	Disease	MESH:D000690
20880000	444	452	patients	Species	9606
20880000	467	470	ALS	Disease	MESH:D000690
20880000	582	595	motor disease	Disease	MESH:D004194
20880000	648	651	ALS	Disease	MESH:D000690
20880000	730	738	patients	Species	9606
20880000	744	747	ALS	Disease	MESH:D000690
20880000	752	755	ALS	Disease	MESH:D000690
20880000	784	792	Patients	Species	9606
20880000	862	865	ALS	Disease	MESH:D000690
20880000	875	880	ApoE2	Gene	348
20880000	897	902	ApoE3	Gene	348
20880000	919	924	ApoE4	Gene	348
20880000	991	994	ALS	Disease	MESH:D000690
20880000	1009	1014	ApoE2	Gene	348
20880000	1031	1036	ApoE3	Gene	348
20880000	1053	1058	ApoE4	Gene	348
20880000	1106	1126	cognitively impaired	Disease	MESH:D003072
20880000	1129	1134	ApoE2	Gene	348
20880000	1143	1148	ApoE3	Gene	348
20880000	1157	1162	ApoE4	Gene	348
20880000	1204	1209	ApoE2	Gene	348
20880000	1226	1231	ApoE3	Gene	348
20880000	1248	1253	ApoE4	Gene	348
20880000	1377	1380	ALS	Disease	MESH:D000690
20880000	1459	1461	AD	Disease	MESH:D000544
20880000	1472	1499	neurodegenerative disorders	Disease	MESH:D019636
20880000	Association	MESH:D000690	348
20880000	Association	MESH:D003072	348
20880000	Positive_Correlation	MESH:D000544	348

